Expression of miR-630 associated with tyrosine kinase inhibitor therapeutic response in lung adenocarcinoma cases
- PMID: 30997190
- PMCID: PMC6424790
- DOI: 10.21037/jtd.2019.01.92
Expression of miR-630 associated with tyrosine kinase inhibitor therapeutic response in lung adenocarcinoma cases
Conflict of interest statement
Conflicts of Interest: The author has no conflicts of interest to declare.
Comment on
-
A low microRNA-630 expression confers resistance to tyrosine kinase inhibitors in EGFR-mutated lung adenocarcinomas via miR-630/YAP1/ERK feedback loop.Theranostics. 2018 Feb 2;8(5):1256-1269. doi: 10.7150/thno.22048. eCollection 2018. Theranostics. 2018. PMID: 29507618 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources